MWNA
TTOO

Marshall Wace North America’s T2 Biosystems, Inc TTOO Stock Holding History

Marshall Wace North America’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1
Closed -$10K – 1676
2019
Q3 		$10K Buy
+1
New +$8.03K ﹤0.01% 1261
2019
Q1 		– Sell
-1
Closed -$22K – 1982
2018
Q4 		$22K Buy
+1
New +$23.5K ﹤0.01% 1387
2018
Q3 		– Sell
-2
Closed -$87K – 1461
2018
Q2 		$87K Buy
+2
New +$75.9K ﹤0.01% 1323

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace North America's TTOO Position: Q4 2019 in Review

Marshall Wace North America sold out of T2 Biosystems, Inc (TTOO) in Q4 2019, closing a stake of 1 share — an estimated $10K sold.

Marshall Wace North America first reported a position in TTOO in Q2 2018 and held it in 3 quarters. The position peaked at $87K in Q2 2018. 43 funds tracked by Wall St. Rank hold TTOO as of Q4 2019.

  • Marshall Wace North America reported no remaining T2 Biosystems, Inc position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace North America sold 1 T2 Biosystems, Inc share in Q4 2019, an estimated $10K.
  • Marshall Wace North America first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 3 quarters.
  • Marshall Wace North America's T2 Biosystems, Inc position peaked at $87K in Q2 2018.
  • 43 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.